# CSL strikes $1.6B deal with Alentis for experimental kidney, liver drug — retained record

> Retained news record from news:seeking-alpha.

Canonical: https://highsignal.app/data/records/8d6b132e12dc38a0

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:seeking-alpha)  published 2026-10-04 22:41 ingested 2026-10-05 02:56

[original source ↗](https://seekingalpha.com/news/4650048-csl-strikes-16b-deal-with-alentis-for-experimental-kidney-liver-drug?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news)

## retained text

No document body was retained for this record — only its metadata was stored.

document fetched 2026-10-05 02:56 · canonical https://seekingalpha.com/news/4650048-csl-strikes-16b-deal-with-alentis-for-experimental-kidney-liver-drug?feed_item_type=news